Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion J Chatfield

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|August 25, 2015
Avoid the perils of using rounded dataPhil J Borman, Marion J Chatfield
Analytical Chemistry|November 21, 2009
Acceptance criteria for method equivalency assessmentsMarion J Chatfield, Phil J Borman
Analytica Chimica Acta|September 6, 2011
Method ruggedness studies incorporating a risk based approach: a tutorialPhil J Borman, Marion J Chatfield, Ivana Damjanov, et al.
Analytical Chemistry|November 21, 2009
Design and analysis of method equivalence studiesPhil J Borman, Marion J Chatfield, Ivana Damjanov, et al.
Rapid Communications in Mass Spectrometry : RCM|January 31, 2007
Investigation into the factors affecting accuracy of mass measurements on a time-of-flight mass spectrometer using Design of ExperimentAlice M-F Laures, Jean-Claude Wolff, Christine Eckers, et al.
Rapid Communications in Mass Spectrometry : RCM|December 10, 2008
Trace level impurity method development with high-field asymmetric waveform ion mobility spectrometry: systematic study of factors affecting the performanceElodie Champarnaud, Alice M-F Laures, Phil J Borman, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 7, 2008
Development, validation and transfer into a factory environment of a liquid chromatography tandem mass spectrometry assay for the highly neurotoxic impurity FMTP (4-(4-fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine) in paroxetine active pharmaceutical ingredient (API)Phil J Borman, Marion J Chatfield, Elizabeth L Crowley, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Pharmaceutical and Biomedical Analysis|August 25, 2015
Avoid the perils of using rounded dataPhil J Borman, Marion J Chatfield
Analytical Chemistry|November 21, 2009
Acceptance criteria for method equivalency assessmentsMarion J Chatfield, Phil J Borman
Analytica Chimica Acta|September 6, 2011
Method ruggedness studies incorporating a risk based approach: a tutorialPhil J Borman, Marion J Chatfield, Ivana Damjanov, et al.
Analytical Chemistry|November 21, 2009
Design and analysis of method equivalence studiesPhil J Borman, Marion J Chatfield, Ivana Damjanov, et al.
Rapid Communications in Mass Spectrometry : RCM|January 31, 2007
Investigation into the factors affecting accuracy of mass measurements on a time-of-flight mass spectrometer using Design of ExperimentAlice M-F Laures, Jean-Claude Wolff, Christine Eckers, et al.
Rapid Communications in Mass Spectrometry : RCM|December 10, 2008
Trace level impurity method development with high-field asymmetric waveform ion mobility spectrometry: systematic study of factors affecting the performanceElodie Champarnaud, Alice M-F Laures, Phil J Borman, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 7, 2008
Development, validation and transfer into a factory environment of a liquid chromatography tandem mass spectrometry assay for the highly neurotoxic impurity FMTP (4-(4-fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine) in paroxetine active pharmaceutical ingredient (API)Phil J Borman, Marion J Chatfield, Elizabeth L Crowley, et al.
Pageof 1